The Centre for In Vivo Modelling is a newly established research centre within the Division of Cancer Biology at the ICR. Our scientists and clinical researchers use state-of-the-art in vivo models to ...

Scientists have provided fresh insight into one of the earliest stages of global genome nucleotide excision repair (NER) – a pathway that continuously scans DNA for damage throughout the genome. By ...

A new study has revealed a promising therapeutic strategy for pancreatic cancer, offering new hope for people living with this disease. The findings showed that a combination of two existing ...

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...

Being overweight or obese is an important cause of rising cancer rates among younger adults in England, according to a major new study. Researchers at The Institute of Cancer Research, London, and ...

A new immunotherapy drug has shown promise for safely treating prostate cancer, a phase I trial reports. Almost half of the patients in the trial that could be evaluated saw their tumour shrink after ...

These days, in the era of personalised medicine, whenever researchers discover a new cancer drug they are expected to show exactly how it works and to prove that it is exerting its therapeutic effect ...

Scientists have developed an AI-powered method that could determine which patients with advanced bowel cancer are most likely to respond to a targeted drug used on the NHS – potentially sparing ...

Radiotheranostics is an exciting new field that has the potential to transform how cancers are detected and treated. Robbie Lockyer finds out more. Radiotheranostics, a groundbreaking approach that ...

Two ground-breaking studies have demonstrated that combining artificial intelligence (AI) with state-of-the-art MRI imaging could revolutionise how clinicians detect, monitor and treat advanced ...

Regular leisure time physical activity may reduce the risk of breast cancer for women before menopause, according to new research funded by Breast Cancer Now. The research, published today (Monday 11 ...

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, ...